Weight management is usually more strongly influenced by nutrition, physical activity, sleep, and treatment of underlying health conditions
Some patients continue to experience symptoms despite using these medications
It estimated that in 2022 there were 2.5 billion adults (18 years and older) who were overweight, including more than 890 million who were obese
Their unique dual-action mechanism targets both GIP and GLP-1 receptors, helping to regulate appetite, improve metabolism, and support greater fat reduction compared to medications that target only GLP-1 receptors
Understanding interactions and synergies helps develop comprehensive management strategies
Regular consultations with healthcare professionals, coupled with adherence to storage and expiration guidelines, create a solid foundation for effective treatment